Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2,4-Dichloropyrimidine → Methyl 2-(2-chloropyrimidin-4-yl)-5-methylbenzoate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2,4-Dichloropyrimidine | HCID 77531 | — |
| 반응물 | Methyl 5-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | HCID 46856403 | — |
| 반응물 | Methyl 5-methyl-2-(1-methyl-1H-pyrazol-4-yl)benzoate | HCID 117727848 | — |
| 생성물 | Methyl 2-(2-chloropyrimidin-4-yl)-5-methylbenzoate | HCID 117727617 | — |
반응 단계
The title compound was synthesized following the same general protocol as described for methyl 5-methyl-2-(1-methyl-1H-pyrazol-4-yl)benzoate in Example A1, using methyl 5-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate and 2,4-dichloropyrimidine. ESI-MS (m/z): 263 [M+1]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09440982B2 |
| 출처 데이터셋 | uspto-grants-2016_09 |
| ORD ID | ord-5d81e4ba5f6343f09f530925509d1f00 |
| 출처 메모 | uspto-grants-2016_09 |